Chemotherapy: Open Access
Open Access
ISSN: 2167-7700
ISSN: 2167-7700
Partow Kebriaei
Associate Professor, Department of Stem Cell Transplant and Cellular Therapy
University of Texas, USA
The University of TexasDr. Partow Kebriaei is an Associate Professor in the Department of Stem Cell Transplant and Cellular Therapy at the MD Anderson Cancer Center in Houston, Texas. She completed her Hematology and Oncology fellowship training at the University of Chicago, and began her tenure at MD Anderson in 2003. Dr. Kebriaei’s research interests include therapy of leukemias, in particular acute lymphoblastic leukemia, as well as autologous and allogeneic stem cell transplantation for lymphoma and leukemia. She is interested in the development of novel transplant preparative regimens that may have less regimen-related toxicity, and increased disease efficacy. Dr. Kebriaei has authored numerous reviews, book chapters, and papers, and serves as a reviewer for major hematology and oncology publications. She is an active member of hematology and oncology professional societies including American Association for Cancer Research, American Society of Hematology, American Society of Clinical Oncology, and American Society for Blood and Marrow Transplantation.
She is interested in investigating the use of traditional chemotherapeutic agents in combination with cellular therapies and adoptive immunotherapy to develop more effective treatment regimens. Work toward this aim includes investigating the use CD19-directed T cell therapy for lymphoid malignancies, using umbilical cord blood in combination with a standard allogeneic peripheral blood stem cell transplant to augment the graft versus leukemia effect, and investigating the use of mesenchymal stem cells for the therapy of graft versus host disease.